Protein prenylation contributes to the effects of LPS on EFS-induced responses in human isolated bronchi

American Journal of Respiratory Cell and Molecular Biology

Volumn 45, Issue 4, 2011, Pages 704-710

  Cazzola, Mario ^a,d   Calzetta, Luigino ^a,b   Page, Clive P ^b   Rinaldi, Barbara ^c   Capuano, Annalisa ^c   Matera, Maria Gabriella ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d Instituto di Ricovero e Cura a Carattere Scientifico   (Italy)

Author keywords

EFS; Human bronchi; LPS; Rho Ras signaling pathways; Statins

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; FARNESYL DIPHOSPHATE; FARNESYL TRANS TRANSFERASE; GERANYLGERANYL PYROPHOSPHATE; GERANYLGERANYLTRANSFERASE; GGTI 2133; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; LIPOPOLYSACCHARIDE; N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE; PROTEIN; RAS PROTEIN; RHO FACTOR; SIMVASTATIN; TRANSFERASE; TRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRONCHOSPASM; BRONCHUS; ELECTROSTIMULATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MUSCLE FORCE; NORMAL HUMAN; PROTEIN PRENYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; STIMULUS RESPONSE; TIME;

ALKYL AND ARYL TRANSFERASES; AMIDES; BRONCHI; BRONCHOCONSTRICTION; ELECTRIC STIMULATION; ENZYME INHIBITORS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMIDAZOLES; LEUCINE; LIPOPOLYSACCHARIDES; MALE; METHIONINE; MIDDLE AGED; NAPHTHALENES; POLYISOPRENYL PHOSPHATES; PROTEIN KINASE INHIBITORS; PROTEIN PRENYLATION; PYRIDINES; RAS PROTEINS; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; SESQUITERPENES; SIGNAL TRANSDUCTION; SIMVASTATIN; TIME FACTORS;

EID: 80053625994     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0306OC     Document Type: Article

References (64)

1. Vernooy JH, Dentener MA, van Suylen RJ, Buurman WA, Wouters EF. Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology. Am J Respir Cell Mol Biol 2002;26:152-159. (Pubitemid 34029832)
2. Toward TJ, Broadley KJ. Airway reactivity, inflammatory cell influx and nitric oxide in guinea-pig airways after lipopolysaccharide inhalation. Br J Pharmacol 2000;131:271-281.
3. Lefort J, Motreff L, Vargaftig BB. Airway administration of Escherichia coli endotoxin to mice induces glucocorticosteroid-resistant bronchoconstriction and vasopermeation. Am J Respir Cell Mol Biol 2001;24: 345-351. (Pubitemid 32228384)
4. Jagielo PJ, Thorne PS, Watt JL, Frees KL, Quinn TJ, Schwartz DA. Grain dust and endotoxin inhalation challenges produce similar inflammatory responses in normal subjects. Chest 1996;110:263-270. (Pubitemid 26249332)
5. Vargaftig BB. Modifications of experimental bronchopulmonary hyperresponsiveness. Am J Respir Crit Care Med 1997;156:S97-S102. (Pubitemid 27449320)
6. Rocksen D, Ekstrand-Hammarstrom B, Johansson L, Bucht A. Vitamin E reduces transendothelial migration of neutrophils and prevents lung injury in endotoxin-induced airway inflammation. Am J Respir Cell Mol Biol 2003;28:199-207. (Pubitemid 36169649)
7. Brigham KL, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis 1986;133:913-927. (Pubitemid 16116524)
8. Schaafsma D, Roscioni SS, Meurs H, Schmidt M. Monomeric G-proteins as signal transducers in airway physiology and pathophysiology. Cell Signal 2008;20:1705-1714.
9. Michel O, Duchateau J, Sergysels R. Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. J Appl Physiol 1989;66:1059-1064. (Pubitemid 19091329)
10. Hippenstiel S, Soeth S, Kellas B, Fuhrmann O, Seybold J, Krull M, Eichel-Streiber C, Goebeler M, Ludwig S, Suttorp N. Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells. Blood 2000;95:3044-3051.
11. Essler M, Staddon JM, Weber PC, Aepfelbacher M. Cyclic AMP blocks bacterial lipopolysaccharide-induced myosin light chain phosphorylation in endothelial cells through inhibition of Rho/Rho kinase signaling. J Immunol 2000;164:6543-6549. (Pubitemid 30408840)
12. Molimard M, Naline E, Boichot E, Devillier P, Lagente V, Begaud B, Advenier C. In vitro-induced human airway hyperresponsiveness to bradykinin. Eur Respir J 1998;12:1301-1306. (Pubitemid 29011419)
13. Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein rho. EMBO J 1996;15:2208-2216. (Pubitemid 26141137)
14. Schaafsma D, Bos IS, Zuidhof AB, Zaagsma J, Meurs H. Inhalation of the Rho-kinase inhibitor Y-27632 reverses allergen-induced airway hyperresponsiveness after the early and late asthmatic reaction. Respir Res 2006;7:121.
15. Schaafsma D, Gosens R, Bos IS, Meurs H, Zaagsma J, Nelemans SA. Allergic sensitization enhances the contribution of Rho-kinase to airway smooth muscle contraction. Br J Pharmacol 2004;143:477-484. (Pubitemid 39452215)
16. Stamatakis K, Cernuda-Morollon E, Hernandez-Perera O, Perez-Sala D. Isoprenylation of RhoB is necessary for its degradation: a novel determinant in the complex regulation of RhoB expression by the mevalonate pathway. J Biol Chem 2002;277:49389-49396. (Pubitemid 36014371)
17. Monick MM, Powers LS, Butler NS, Hunninghake GW. Inhibition of Rho family GTPases results in increased TNF-alpha production after lipopolysaccharide exposure. J Immunol 2003;171:2625-2630. (Pubitemid 37025575)
18. Li Y, Wu Y, Wang Z, Zhang XH, Wu WK. Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice through the Rho/Rho kinase pathway. Med Sci Monit 2010;16:BR112-BR118.
19. Takeda N, Kondo M, Ito S, Ito Y, Shimokata K, Kume H. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin. Am J Respir Cell Mol Biol 2006;35:722-729. (Pubitemid 44901862)
20. Vigano T, Hernandez A, Corsini A, Granata A, Belloni P, Fumagalli R, Paoletti R, Folco G.Mevalonate pathway and isoprenoids regulate human bronchial myocyte proliferation. Eur J Pharmacol 1995;291:201-203.
21. Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, Obinata T, Ohashi K, Mizuno K, Narumiya S. Signaling from rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 1999;285:895-898. (Pubitemid 29381991)
22. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000;351:95-105.
23. Matera MG, Calzetta L, Parascandolo V, Curradi G, Rogliani P, Cazzola M. Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi. Pulm Pharmacol Ther 2009;22:478-482.
24. Naline E, Zhang Y, Qian Y, Mairon N, Anderson GP, Grandordy B, Advenier C. Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus. Eur Respir J 1994;7:914-920. (Pubitemid 24153592)
25. Binks AP, Paydarfar D, Schachter SC, Guz A, Banzett RB. High strength stimulation of the vagus nerve in awake humans: a lack of cardiorespiratory effects. Respir Physiol 2001;127:125-133. (Pubitemid 32720501)
26. Cohen-Jonathan E, Toulas C, Ader I, Monteil S, Allal C, Bonnet J, Hamilton AD, Sebti SM, Daly-Schveitzer N, Favre G. The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in Hela cells expressing wild-type Ras. Radiat Res 1999;152:404-411. (Pubitemid 29463618)
27. Massy ZA, Guijarro C, Oda H, Kasiske BL, Keane WF, O'Donnell MP. Importance of geranylgeranyl pyrophosphate for mesangial cell DNA synthesis. Kidney Int Suppl 1999;71:S80-S83. (Pubitemid 29304820)
28. Tamaoki J, Tagaya E, Sakai A, Konno K. Effects of macrolide antibiotics on neurally mediated contraction of human isolated bronchus. J Allergy Clin Immunol 1995;95:853-859.
29. Vasudevan A, Qian Y, Vogt A, Blaskovich MA, Ohkanda J, Sebti SM, Hamilton AD. Potent, highly selective, and non-thiol inhibitors of protein geranylgeranyltransferase-i. J Med Chem 1999;42:1333-1340. (Pubitemid 29200868)
30. Qian Y, Vogt A, Vasudevan A, Sebti SM, Hamilton AD. Selective inhibition of type-I geranylgeranyltransferase in vitro and in whole cells by caal peptidomimetics. Bioorg Med Chem 1998;6:293-299. (Pubitemid 28144480)
31. Goossens L, Deweer S, Pommery J, Henichart JP, Goossens JF. Spectroscopic study of fluorescent peptides for prenyl transferase assays. J Pharm Biomed Anal 2005;37:417-422. (Pubitemid 40312283)
32. Kenakin TP. The schild regression in the process of receptor classification. Can J Physiol Pharmacol 1982;60:249-265. (Pubitemid 12144825)
33. Motulsky H, Christopoulos A. Fitting models to biological data using linear and nonlinear regression: a practical guide to curve fitting. Oxford: Oxford University Press; 2004.
34. Mercier FJ, Naline E, Bardou M, Georges O, Denjean A, Benhamou D, Advenier C. Relaxation of proximal and distal isolated human bronchi by halothane, isoflurane and desflurane. Eur Respir J 2002;20:286-292.
35. Wang SL, Xie DP, Liu KJ, Qin JF, Feng M, Kunze W, Liu CY. Nitric oxide mediates the inhibitory effect of ethanol on the motility of isolated longitudinal muscle of proximal colon in rats. Neurogastroenterol Motil 2007;19:515-521.
36. Saito M, Broderick GA, Hypolite JA, Levin RM. Pharmacological effect of ethanol on the function of rabbit corporal cavernosal tissue. Pharmacology 1994;48:335-340. (Pubitemid 24103620)
37. Jarreau PH, D'Ortho MP, Boyer V, Harf A, Macquin-Mavier I. Effects of capsaicin on the airway responses to inhaled endotoxin in the guinea pig. Am J Respir Crit Care Med 1994;149:128-133. (Pubitemid 24066108)
38. Loeffler BS, Arden WA, Fiscus RR, Lee LY. Involvement of tachykinins in endotoxin-induced airway hyperresponsiveness. Lung 1997;175:253-263. (Pubitemid 27260314)
39. Michel O, Nagy AM, Schroeven M, Duchateau J, Neve J, Fondu P, Sergysels R. Dose-response relationship to inhaled endotoxin in normal subjects. Am J Respir Crit Care Med 1997;156:1157-1164.
40. Kharitonov SA, Sjobring U. Lipopolysaccharide challenge of humans as a model for chronic obstructive lung disease exacerbations. Contrib Microbiol 2007;14:83-100.
41. Person RJ. Actions of endotoxins on excitation-secretion coupling at the neural membrane. Prog Clin Biol Res 1981;62:65-79.
42. Marek W, Ozyurt M, Potthast J, Mensing T. Endotoxin-induced airway hyperresponsiveness in rabbits: contribution of neuropeptides. J Physiol Pharmacol 2008;59:421-432.
43. Fatehi-Hassanabad Z, Furman BL, Parratt JR. The effect of endotoxin on sympathetic responses in the rat isolated perfused mesenteric bed; involvement of nitric oxide and cyclo-oxygenase products. Br J Pharmacol 1995;116:3316-3322. (Pubitemid 26007778)
44. Goetzl EJ, An S. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J 1998;12:1589-1598. (Pubitemid 28553654)
45. Morimoto K, Janssen WJ, Fessler MB, McPhillips KA, Borges VM, Bowler RP, Xiao YQ, Kench JA, Henson PM, Vandivier RW. Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol 2006;176:7657-7665. (Pubitemid 43849066)
46. Sun J, Qian Y, Hamilton AD, Sebti SM. Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts. Oncogene 1998;16:1467-1473. (Pubitemid 28151853)
47. Chiba Y, Sakai H, Misawa M. Augmented acetylcholine-induced translocation of RhoA in bronchial smooth muscle from antigen-induced airway hyperresponsive rats. Br J Pharmacol 2001;133:886-890. (Pubitemid 32751798)
48. Shinozaki S, Inoue Y, Yang W, Fukaya M, Carter EA, Ming-Yu Y, Fischman A, Tompkins R, Kaneki M. Farnesyltransferase inhibitor improved survival following endotoxin challenge in mice. Biochem Biophys Res Commun 2010;391:1459-1464.
49. Iizuka K, Shimizu Y, Tsukagoshi H, Yoshii A, Harada T, Dobashi K, Murozono T, Nakazawa T, Mori M. Evaluation of Y-27632, a Rho-kinase inhibitor, as a bronchodilator in guinea pigs. Eur J Pharmacol 2000;406:273-279.
50. Buyukafsar K, Levent A, Ark M. Expression of Rho-kinase and its functional role in the contractile activity of the mouse vas deferens. Br J Pharmacol 2003;140:743-749. (Pubitemid 37386439)
51. Buyukafsar K, Un I. Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice. Eur J Pharmacol 2003;472:235-238. (Pubitemid 37271921)
52. Buyukafsar K, Levent A. Involvement of Rho/Rho-kinase signalling in the contractile activity and acetylcholine release in the mouse gastric fundus. Biochem Biophys Res Commun 2003;303:777-781. (Pubitemid 36384922)
53. Levent A, Buyukafsar K. Expression of Rho-kinase (ROCK-1 and ROCK-2) and its substantial role in the contractile activity of the sheep ureter. Br J Pharmacol 2004;143:431-437. (Pubitemid 39424832)
54. Wibberley A, Chen Z, Hu E, Hieble JP, Westfall TD. Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle. Br J Pharmacol 2003;138:757-766. (Pubitemid 36390631)
55. Kume H. RhoA/Rho-kinase as a therapeutic target in asthma. Curr Med Chem 2008;15:2876-2885.
56. Henry PJ, Mann TS, Goldie RG. A Rho kinase inhibitor, Y-27632 inhibits pulmonary eosinophilia, bronchoconstriction and airways hyperresponsiveness in allergic mice. Pulm Pharmacol Ther 2005;18:67-74. (Pubitemid 39647755)
57. Liao JK, Seto M, Noma K. Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol 2007;50:17-24. (Pubitemid 47220442)
58. Maneechotesuwan K, Ekjiratrakul W, Kasetsinsombat K, Wongkajornsilp A, Barnes PJ. Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase. J Allergy Clin Immunol 2010;126:754-762.
59. Ahmad T, Mabalirajan U, Sharma A, Aich J, Makhija L, Ghosh B, Agrawal A. Simvastatin improves epithelial dysfunction and airway hyperresponsiveness: from ADMA to asthma. Am J Respir Cell Mol Biol 2011;44:531-539.
60. Schaafsma D, Dueck G, Ghavami S, Kroeker A, Mutawe MM, Hauff K, Xu FY, McNeill KD, Unruh H, Hatch GM, et al. The mevalonate cascade as a target to suppress extracellular matrix synthesis by human airway smooth muscle. Am J Respir Cell Mol Biol 2011;44:394-403.
61. Croxton TL, Lande B, Hirshman CA. Role of g proteins in agonist-induced Ca21 sensitization of tracheal smooth muscle. Am J Physiol 1998;275:L748-L755.
62. Xue X, Lai KT, Huang JF, Gu Y, Karlsson L, Fourie A. Antiinflammatory activity in vitro and in vivo of the protein farnesyltransferase inhibitor tipifarnib. J Pharmacol Exp Ther 2006;317:53-60.
63. Luo SF, Wang CC, Chiu CT, Chien CS, Hsiao LD, Lin CH, Yang CM. Lipopolysaccharide enhances bradykinin-induced signal transduction via activation of Ras/Raf/MEK/MAPK in canine tracheal smooth muscle cells. Br J Pharmacol 2000;130:1799-1808. (Pubitemid 30655790)
64. Lin WN, Luo SF, Lin CC, Hsiao LD, Yang CM. Differential involvement of PKC-dependent MAPKs activation in lipopolysaccharideinduced AP-1 expression in human tracheal smooth muscle cells. Cell Signal 2009;21:1385-1395.